List of Authors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
List of Authors
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Sepha
Detlev Haack,
Mattias Haag
Bryan Haas
Klaus Haberer
Martin Hack
Lara Haddad
Friedrich Haefele
Bonnie Haferkamp
Dr. Fredrick Haibach
Susan Haigney
Daniel Haines
Roger Halbert
Ian Haley
Janis Hall
Mark J. Hall
Trevor J. Hallam
Michael F. Haller, PhD
Chris Halling
Sheelagh Halsey
James Hamby
Chris Hamilton
Leo Hammendorp
Bruno C. Hancock
Melissa Hanna-Brown
Jelle Hanse
Gordon Hansen
Kris J. Hansen
Kris Hansen
Steve Hansen
Chris Hansford
Lisa Hardwick
John Hargreaves
Madhusudan Hariharan
Chan Harjivan
Anthony Harnack
Leah Harris
Brianne Harrison
George Hartford
Jeffrey L. Hartman
Jeffrey Hartman
Masaki Hasegawa
Brian Hasselbalch
Walter W. Hauck, PhD
Alastair Hay
Heather B. Hayes
John M. Hayes
Donald T. Haynie
NSF Health Sciences
Barry Heavey
Pamela Hecht
David B. Hedden
Bill Hedgepeth
William Hedgepeth
Roy Helmy, PhD
Christian Hemming
Christian Hemmingsen
Ryan Henary
Andrew Henderson
Sheryl Henderson
David Henderson JR
Walter D. Henkels
Hartmut Hennig
Felix Henning
Eldon Henson
Clifford J. Herman
Antonio Hernandez-Cardoso
Elizabeth Hewitt
Steve Hewitt
Susanne Hibler
A.J. Hickey
Michael B. Higgins
Trevor Higgins
Clay Hile
Eric Hill
Nicole L. Hill
Michael Hindle
Gary Hindman, Ph.D.
Wouter L.J. Hinrichs
Hiroshi Hirasawa
Jeffrey Hirsch
Tony Hitchcock
Pradip Hiwale
Yukio Hiyama
Stephen W. Hoag
David W. Hobson
Aden Hodzic
Boon Meow Hoe
Jeff Hofer
Jeffrey D. Hofer
Michelle Hoffman
Janice M. Hogan
Gerard Hokanson
R. Gary Hollenbeck
Kevin M. Holman
David Holovac
Dr. Jay T. Holt
Karen E. Holt-Tiffin
. Holte
Frithjof Holtz
Back to Top

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here